Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Drug Development Research
|
January 6, 2023
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Hong-Yi Zhao, Minhang Xin, San-Qi Zhang
Bioorganic Chemistry
|
August 14, 2022
Overcoming C797S mutation: The challenges and prospects of the fourth-generation EGFR-TKIs
Hong-Yi Zhao, Xiao-Xiao Xi, Minhang Xin, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2020
Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors
Jiajia Sun, Yifan Feng, Yuan Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2017
Design and synthesis of novel 6-aryl substituted 4-anilinequinazoline derivatives as potential PI3Kδ inhibitors
Minhang Xin, Yuan-Yuan Hei, Hao Zhang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
September 30, 2008
[Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles]
Jin-juan Li, Guang-de Yang, Hong-ying Wang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
August 4, 2007
[Application of macroporous resin in purification for effective part from Polygonum cuspidatum]
Dan Liu, Hai-feng Tang, San-qi Zhang, et al.
Expert Opinion on Therapeutic Patents
|
February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)
Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 8, 2015
Discovery of novel 2-benzylisoquinolin-1(2H)-ones as potent vasodilative agents
Bo-Rui Kang, Sen Li, Shuai Mao, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2025
Synthesis and degradation effect of PROTACs targeting EGFR triple mutants
Xiao-Xiao Xi, Hong-Yi Zhao, Minhang Xin, et al.
Bioorganic & Medicinal Chemistry
|
August 23, 2019
Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitors
Yifan Feng, Weiming Duan, Shu Fan, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Drug Development Research
|
January 6, 2023
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Hong-Yi Zhao, Minhang Xin, San-Qi Zhang
Bioorganic Chemistry
|
August 14, 2022
Overcoming C797S mutation: The challenges and prospects of the fourth-generation EGFR-TKIs
Hong-Yi Zhao, Xiao-Xiao Xi, Minhang Xin, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2020
Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors
Jiajia Sun, Yifan Feng, Yuan Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2017
Design and synthesis of novel 6-aryl substituted 4-anilinequinazoline derivatives as potential PI3Kδ inhibitors
Minhang Xin, Yuan-Yuan Hei, Hao Zhang, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
September 30, 2008
[Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles]
Jin-juan Li, Guang-de Yang, Hong-ying Wang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
August 4, 2007
[Application of macroporous resin in purification for effective part from Polygonum cuspidatum]
Dan Liu, Hai-feng Tang, San-qi Zhang, et al.
Expert Opinion on Therapeutic Patents
|
February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)
Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 8, 2015
Discovery of novel 2-benzylisoquinolin-1(2H)-ones as potent vasodilative agents
Bo-Rui Kang, Sen Li, Shuai Mao, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2025
Synthesis and degradation effect of PROTACs targeting EGFR triple mutants
Xiao-Xiao Xi, Hong-Yi Zhao, Minhang Xin, et al.
Bioorganic & Medicinal Chemistry
|
August 23, 2019
Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitors
Yifan Feng, Weiming Duan, Shu Fan, et al.
Page
of 8